NASDAQ:OMED - Oncomed Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$0.8005 +0.01 (+1.27 %)
(As of 12/16/2018 05:21 AM ET)
Previous Close$0.8005
Today's Range$0.7301 - $0.8660
52-Week Range$0.73 - $4.20
Volume1.70 million shs
Average Volume414,769 shs
Market Capitalization$30.52 million
P/E Ratio-0.77
Dividend YieldN/A

Analyst Ratings

Oncomed Pharmaceuticals (NASDAQ:OMED) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Oncomed Pharmaceuticals in the last 12 months. Their average twelve-month price target is $3.1667, suggesting that the stock has a possible upside of 295.59%. The high price target for OMED is $6.00 and the low price target for OMED is $1.50. There are currently 3 hold ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score:
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $3.1667$4.00$4.50$4.60
Price Target Upside: 295.59% upside65.98% upside46.10% upside49.35% upside

Oncomed Pharmaceuticals (NASDAQ:OMED) Consensus Price Target History

Price Target History for Oncomed Pharmaceuticals (NASDAQ:OMED)

Oncomed Pharmaceuticals (NASDAQ:OMED) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/6/2018Wells Fargo & CoReiterated RatingOutperform ➝ Market Perform$8.00 ➝ $1.50HighView Rating Details
9/21/2018HC WainwrightLower Price TargetNeutral$3.00 ➝ $2.00HighView Rating Details
1/4/2018Cantor FitzgeraldSet Price TargetHold$6.00HighView Rating Details
10/6/2017SunTrust BanksReiterated RatingHold$4.00N/AView Rating Details
9/28/2017Jefferies Financial GroupReiterated RatingBuy$5.00LowView Rating Details
7/10/2017Piper Jaffray CompaniesSet Price TargetHold$5.00MediumView Rating Details
4/17/2017JMP SecuritiesDowngradeOutperform ➝ Market PerformLowView Rating Details
4/11/2017Leerink SwannBoost Price TargetMarket Perform$6.00 ➝ $10.00HighView Rating Details
4/11/2017BMO Capital MarketsDowngradeOutperform ➝ Market Perform$6.00HighView Rating Details
(Data available from 12/16/2016 forward)
This page was last updated on 12/16/2018 by Staff

Featured Article: What is a Derivative?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel